Philips and University Medical Center Hamburg-Eppendorf to test the
world’s first MRI/PET image software tool for the diagnosis of neurodegenerative
diseases.
HAMBURG, GERMANY - The University Medical Center Hamburg-Eppendorf (UKE)
and Royal Philips Electronics have developed a computer aided diagnostics (CAD)
system for neurodegenerative diseases to support clinicians in diagnosing the
onset and type of disease as early as possible. The new diagnostic technique,
which has already proven its accuracy using historical image data and known
patient outcomes, is about to undergo clinical evaluation at UKE.
The CAD system is a software package that automatically interprets PET (Positron
Emission Tomography) brain scans of patients suspected of having a
neurodegenerative disease that leads to dementia, and combines them with MRI
(Magnetic Resonance Imaging) scans for accurate differential diagnosis. The
development of such a system will ultimately mean a better quality of life for
patients by enabling earlier prescription of drugs that delay progression of the
disease, and hence delay the worst effects of dementia. It will also provide
pharmaceutical companies and clinicians with a valuable tool for the development
and testing of new, potentially curative drugs for neurodegenerative diseases
such as Alzheimer’s.
“In the not too distant future there is going to be much greater demand for the
accurate early diagnosis of neurodegenerative disease and not everyone will have
access to the clinical expertise of a university hospital to obtain it,” says
Dr. Ralph Buchert of the Department of Nuclear Medicine at UKE. “The
availability of an automated system will help less experienced physicians to
achieve the same high level of accuracy in their diagnoses.”
Dementia is a debilitating condition that already affects more than 25 million
people worldwide*, the commonest form being Alzheimer’s disease. As the
demographics of world populations increasingly shift towards older age groups,
dementia is widely expected to reach epidemic proportions unless effective
treatments are found for it.
“Building on our expertise in multi-modal diagnostic imaging, we’ve combined
functional and structural brain-scan information into a fully integrated and
easy to use system for diagnosing the principal neurodegenerative diseases that
cause dementia,” says Dr. Lothar Spies, Head of the Digital Imaging Department
at Philips Research. “Ultimately, it will enable early treatment and highly
personalized therapies.”
The software tool developed by Philips Research and UKE accurately overlays
anatomical images of the brain obtained from MRI scans with PET scans that
display brain activity – specifically the uptake of glucose that fuels brain
activity. By using advanced image processing and computer learning techniques in
combination with a database of reference brain-scans, the system then analyses
the images automatically and displays anomalous brain patterns in a concise way.
Based on these patterns, it then suggests a diagnosis. As a result, the system
will help less experienced doctors to achieve the same diagnostic accuracy as
highly trained specialists.
The clinical evaluation that is about to start will run the computer aided
diagnostic system alongside UKE’s existing dementia diagnosis procedures with
the aim of fine-tuning the system’s ability to detect and differentiate the
three most common types of neurodegenerative disease – Alzheimer’s Disease, Lewy-body
Dementia and Frontotemporal Dementia.
A screenshot of the interface of the Computer Aided Diagnosis
system that automatically interprets PET brain scans of patients
suspected of having a neurodegenerative disease.
A PET scanner is often used to diagnose a neurodegenerative
disease that leads to dementia. The recently developed Philips-UKE Computer
Aided Diagnosis system is a software package that automatically interprets PET
brain scans of patients suspected of having a neurodegenerative disease. The
system will be tested at the UKE.
Philips
Steve Klink
Philips Research / Communications Department
Tel.: +31 40 27 43703
Mobile: +31 6 10888824
E-mail: steve.klink@philips.com
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
global leader in healthcare, lighting and consumer lifestyle, delivering
people-centric, innovative products, services and solutions through the brand
promise of “sense and simplicity”. Headquartered in the Netherlands, Philips
employs approximately 134,200 employees in more than 60 countries worldwide.
With sales of EUR 27 billion in 2007, the company is a market leader in medical
diagnostic imaging and patient monitoring systems, energy efficient lighting
solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at
www.philips.com/newscenter.